Gary Gilkeson to Nitric Oxide Synthase Type II
This is a "connection" page, showing publications Gary Gilkeson has written about Nitric Oxide Synthase Type II.
Connection Strength
0.385
-
Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene. J Investig Med. 2008 Oct; 56(7):911-9.
Score: 0.072
-
Inflammatory modulation of PPAR gamma expression and activity. Clin Immunol. 2006 Feb-Mar; 118(2-3):276-83.
Score: 0.059
-
Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide. J Pharmacol Exp Ther. 2005 Jan; 312(1):69-76.
Score: 0.054
-
Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans. J Rheumatol. 2003 Jan; 30(1):60-7.
Score: 0.048
-
Prostaglandin J(2) inhibition of mesangial cell iNOS expression. Clin Immunol. 2001 Mar; 98(3):337-45.
Score: 0.043
-
Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. J Immunol. 2000 Feb 01; 164(3):1498-504.
Score: 0.040
-
Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians. 1999 Nov-Dec; 111(6):611-21.
Score: 0.039
-
Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum. 2006 Jul; 54(7):2198-210.
Score: 0.015
-
A novel PPAR response element in the murine iNOS promoter. Mol Immunol. 2005 Jul; 42(11):1303-10.
Score: 0.014